DSGN

Design Therapeutics, Inc.

• Seeking Alpha·18h ago

  Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings

• TipRanks·04/02 14:43

  Design Therapeutics management to meet with Oppenheimer

• TipRanks·04/01 20:43

  Design Therapeutics Appoints David Shapiro to Board

• Reuters·04/01 20:12

  Design Therapeutics director David Shapiro files initial beneficial ownership statement

• Reuters·04/01 20:04

  Design Therapeutics appoints David Shapiro to board as Class III director

• Dow Jones·03/16 13:17

  Design Therapeutics Price Target Announced at $15.00/Share by Jefferies

• Benzinga·03/16 13:16

  Jefferies Initiates Coverage On Design Therapeutics with Buy Rating, Announces Price Target of $15

• Reuters·03/16 10:00

  U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics

• Reuters·03/16 08:20

  DESIGN THERAPEUTICS INC <DSGN.O>: JEFFERIES INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $15

• TipRanks·03/16 00:36

  Design Therapeutics (DSGN) Receives a New Rating from a Top Analyst

• TipRanks·03/16 00:15

  Design Therapeutics initiated with a Buy at Jefferies

• Dow Jones·03/10 13:35

  Design Therapeutics Is Maintained at Outperform by RBC Capital

• Benzinga·03/10 13:24

  RBC Capital Maintains Outperform on Design Therapeutics, Raises Price Target to $14

• TipRanks·03/10 13:20

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (DSGN) and Vertex Pharmaceuticals (VRTX)

• TipRanks·03/10 12:40

  Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Design Therapeutics (DSGN) and Cartesian Therapeutics (RNAC)